日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma

可溶性尿激酶型纤溶酶原激活物受体可预测晚期肝细胞癌患者的生存期和肝功能失代偿

Artusa, Fabian; Lamatsch, Sven; Phan, Minh Duc; Özdirik, Burcin; Berger, Hilmar; Egerer, Mara; Knorr-Klocke, Jana; Fischer, Janett; Veelken, Rhea; van Bömmel, Florian; Berg, Thomas; Kappert, Kai; Tauber, Rudolf; Puengel, Tobias; Engelmann, Cornelius; Demir, Münevver; Tacke, Frank; Mohr, Raphael

Acquisition of epithelial plasticity in human chronic liver disease

人类慢性肝病中上皮可塑性的获得

Gribben, Christopher; Galanakis, Vasileios; Calderwood, Alexander; Williams, Eleanor C; Chazarra-Gil, Ruben; Larraz, Miguel; Frau, Carla; Puengel, Tobias; Guillot, Adrien; Rouhani, Foad J; Mahbubani, Krishnaa; Godfrey, Edmund; Davies, Susan E; Athanasiadis, Emmanouil; Saeb-Parsy, Kourosh; Tacke, Frank; Allison, Michael; Mohorianu, Irina; Vallier, Ludovic

Dissecting Acute Drug-Induced Hepatotoxicity and Therapeutic Responses of Steatotic Liver Disease Using Primary Mouse Liver and Blood Cells in a Liver-On-A-Chip Model

利用芯片肝脏模型,通过原代小鼠肝细胞和血细胞分析急性药物诱导的脂肪肝毒性及治疗反应

Liu, Hanyang; Yin, Guo; Kohlhepp, Marlene Sophia; Schumacher, Fabian; Hundertmark, Jana; Hassan, Mohamed I Abdelwahab; Heymann, Felix; Puengel, Tobias; Kleuser, Burkhard; Mosig, Alexander Sandy; Tacke, Frank; Guillot, Adrien

An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH

整合抗炎和抗纤维化靶点治疗非酒精性脂肪性肝炎

Tacke, Frank; Puengel, Tobias; Loomba, Rohit; Friedman, Scott L

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression

血清CXCL5可检测早期肝细胞癌并指示肿瘤进展

Laschtowitz, Alena; Lambrecht, Joeri; Puengel, Tobias; Tacke, Frank; Mohr, Raphael

Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

塞尼西维罗克治疗 COVID-19:一项随机、安慰剂对照、研究者发起、双盲 II 期试验的首批中期结果

Kurth, Florian; Helbig, Elisa T; Lippert, Lena J; Thibeault, Charlotte; Barbone, Gianluca; Eckart, Marius A; Kluge, Martin; Puengel, Tobias; Demir, Münevver; Röhle, Robert; Keller, Theresa; Ruwwe-Glösenkamp, Christoph; Witzenrath, Martin; Suttorp, Norbert; von Kalle, Christof; Sander, Leif E; Jochum, Christoph; Tacke, Frank

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease

核受体在非酒精性脂肪肝疾病中连接代谢、炎症和纤维化

Puengel, Tobias; Liu, Hanyang; Guillot, Adrien; Heymann, Felix; Tacke, Frank; Peiseler, Moritz

Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis

CCR2/CCR5拮抗剂与FGF21类似物联合治疗可协同改善脂肪性肝炎和纤维化

Puengel, Tobias; Lefere, Sander; Hundertmark, Jana; Kohlhepp, Marlene; Penners, Christian; Van de Velde, Frederique; Lapauw, Bruno; Hoorens, Anne; Devisscher, Lindsey; Geerts, Anja; Boehm, Stephanie; Zhao, Qihong; Krupinski, John; Charles, Edgar D; Zinker, Bradley; Tacke, Frank

Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

可溶性尿激酶型纤溶酶原激活物受体水平与原发性硬化性胆管炎患者的纤维化严重程度相关

Özdirik, Burcin; Maibier, Martin; Scherf, Maria; Nicklaus, Jule Marie; Frohme, Josephine; Puengel, Tobias; Meyer Zum Büschenfelde, Dirk; Tacke, Frank; Mueller, Tobias; Sigal, Michael

Monocyte dysregulation: consequences for hepatic infections

单核细胞功能紊乱:对肝脏感染的影响

Sellau, Julie; Puengel, Tobias; Hoenow, Stefan; Groneberg, Marie; Tacke, Frank; Lotter, Hannelore